SAFETY & EFFICACY ARE WHAT MATTERS
Once the shift towards therapeutics being the answer is fully recognized, the promising ones will skyrocket. This has not happened yet but will soon. Big Pharma is eyeing up acquisitions already, ones with proven safety and efficacy will rise to the top.
RVVTF has this, just like the other company RLFTF. Both actually have a 30 year track record as well. I think it is entirely possible they could be used in conjunction at some point. Look at the MOA of bucillamine and do your DD.
That being said, only "traders" are releasing shares. As an investor, I will hang onto my RVVTF position as I see good things coming.
I pick winners...
Best,
JB